1323 related articles for article (PubMed ID: 28058848)
41. Outcomes for patients with anterior myocardial infarction and prior cardiac arrest in the home automated external defibrillator trial (HAT).
Starks MA; Jackson LR; Hellkamp A; Al-Khatib SM; Mark DB; Thomas KL; Nichol G; Lee KL; Davidson-Ray L; Poole J; Anderson J; Johnson G; Bardy GH
Resuscitation; 2021 Nov; 168():75-83. PubMed ID: 34500022
[TBL] [Abstract][Full Text] [Related]
42. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
[TBL] [Abstract][Full Text] [Related]
43. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.
Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Velazquez EJ; Peterson ED; Wang TY
Circulation; 2017 Jan; 135(1):38-47. PubMed ID: 27881561
[TBL] [Abstract][Full Text] [Related]
44. The clinical challenge of preventing sudden cardiac death immediately after acute ST-elevation myocardial infarction.
Manolis AS
Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1427-37. PubMed ID: 25382137
[TBL] [Abstract][Full Text] [Related]
45. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
[TBL] [Abstract][Full Text] [Related]
46. Significant regional variation in use of implantable cardioverter-defibrillators in Denmark.
Pedersen SB; Farkas DK; Hjortshøj SP; Bøtker HE; Johansen JB; Philbert BT; Haarbo J; Thomsen RW; Nielsen JC
Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):352-360. PubMed ID: 30785188
[TBL] [Abstract][Full Text] [Related]
47. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
48. Presentation, Treatment, and Outcome of Survivors of In-Hospital Versus Out-of-Hospital Sudden Cardiac Arrest.
McDermott AT; Polsinelli VB; Wang NC; Kancharla K; Bhonsale A; Jain SK; Saba S
Am J Cardiol; 2020 Apr; 125(8):1137-1141. PubMed ID: 32093953
[TBL] [Abstract][Full Text] [Related]
49. Post-resuscitation care and outcomes of out-of-hospital cardiac arrest: a nationwide propensity score-matching analysis.
Kim JY; Shin SD; Ro YS; Song KJ; Lee EJ; Park CB; Hwang SS;
Resuscitation; 2013 Aug; 84(8):1068-77. PubMed ID: 23454438
[TBL] [Abstract][Full Text] [Related]
50. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
[TBL] [Abstract][Full Text] [Related]
51. Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study.
Rosenkranz SH; Wichmand CH; Smedegaard L; Møller S; Bjerre J; Schou M; Torp-Pedersen C; Philbert BT; Larroudé C; Melchior TM; Nielsen JC; Johansen JB; Riahi S; Holmberg T; Gislason G; Ruwald AC
Eur Heart J Qual Care Clin Outcomes; 2024 Jun; 10(4):314-325. PubMed ID: 37682525
[TBL] [Abstract][Full Text] [Related]
52. Women have a worse prognosis and undergo fewer coronary angiographies after out-of-hospital cardiac arrest than men.
Winther-Jensen M; Hassager C; Kjaergaard J; Bro-Jeppesen J; Thomsen JH; Lippert FK; Køber L; Wanscher M; Søholm H
Eur Heart J Acute Cardiovasc Care; 2018 Aug; 7(5):414-422. PubMed ID: 29064270
[TBL] [Abstract][Full Text] [Related]
53. Temporal trends and long term follow-up of implantable cardioverter defibrillator therapy for secondary prevention: A 15-year single-centre experience.
Caputo ML; Regoli F; Conte G; Adjibodou B; Svab S; Del Bufalo A; Moccetti T; Curti M; Klersy C; Auricchio A
Int J Cardiol; 2017 Feb; 228():31-36. PubMed ID: 27863358
[TBL] [Abstract][Full Text] [Related]
54. Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.
Völler H; Kamke W; Klein HU; Block M; Reibis R; Treusch S; Contzen K; Wegscheider K;
Europace; 2011 Apr; 13(4):499-508. PubMed ID: 21123220
[TBL] [Abstract][Full Text] [Related]
55. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
56. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
Andresen H; Sasko B; Patschan D; Pagonas N; Ritter O
J Med Case Rep; 2021 May; 15(1):243. PubMed ID: 33993888
[TBL] [Abstract][Full Text] [Related]
57. Characteristics and factors associated to patients discharging from hospital without an implantable cardioverter defibrillator after out-of-hospital cardiac arrest.
Sharifzadehgan A; Gaye B; Rischard J; Bougouin W; Karam N; Waldmann V; Narayanan K; Dumas F; Gandjbakhch E; Algalarrondo V; Beganton F; Extramiana F; Lellouche N; Lamhaut L; Jost D; Cariou A; Jouven X; Marijon E
Eur Heart J Acute Cardiovasc Care; 2022 Jul; 11(7):523-531. PubMed ID: 35714122
[TBL] [Abstract][Full Text] [Related]
58. [Primary percutaneous coronary intervention and therapeutic hypothermia in comatose survivors after out-of-hospital cardiac arrest complicating acute myocardial infarction: a single-center experience].
Angeletti C; Ielasi A; Personeni D; Mamprin F; Silvestro A; Saino A; Bertocchi E; Costalunga A; Keim R; Tespili M
G Ital Cardiol (Rome); 2014 May; 15(5):323-9. PubMed ID: 25002173
[TBL] [Abstract][Full Text] [Related]
59. Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable cardioverter-defibrillator eligibility.
Sjöblom J; Muhrbeck J; Witt N; Alam M; Frykman-Kull V
Circulation; 2014 Aug; 130(9):743-8. PubMed ID: 25074505
[TBL] [Abstract][Full Text] [Related]
60. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
Klein HU; Goldenberg I; Moss AJ
Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
